Hormonal Contraceptives Global Market Report 2025

Description

Hormonal contraceptives are a form of birth control that utilizes hormones to prevent pregnancy. There are various types, some of which are reversible, while others are permanent. Certain varieties may also offer protection against sexually transmitted diseases (STDs).

The primary categories of products in oral contraceptive pills include injectable birth control, emergency contraceptive pills, vaginal rings, and others. Oral contraceptive pills, also known as birth control pills, are a class of synthetic steroid hormones that inhibit the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior lobe of the pituitary gland in the female body. These pills come in different hormonal compositions, including progestin-only and combined hormones, and find applications in hospitals, homecare settings, gynecology centers, clinics, and ambulatory surgical centers. Distribution channels for these products include drug stores, gynecology or fertility clinics, e-commerce, and others.

The hormonal contraceptives market research report is one of a series of new reports from The Business Research Company that provides hormonal contraceptives market statistics, including hormonal contraceptives industry global market size, regional shares, competitors with a hormonal contraceptives market share, detailed hormonal contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the hormonal contraceptives industry. This hormonal contraceptive market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal contraceptives market size has grown marginally in recent years. It will grow from $14.16 billion in 2024 to $14.43 billion in 2025 at a compound annual growth rate (CAGR) of 1.9%. The growth in the historic period can be attributed to government initiatives, increase in use of contraceptives, increase in pharmaceutical r&d expenditure, increased healthcare expenditure and growth in the number of healthcare facilities.

The hormonal contraceptives market size is expected to see marginal growth in the next few years. It will grow to $15.53 billion in 2029 at a compound annual growth rate (CAGR) of 1.9%. The growth in the forecast period can be attributed to the increasing awareness on family planning, increasing research and development spending, rise in healthcare expenditure, increasing collaborations between agencies. Major trends in the forecast period include investing in longer lasting vaginal rings, investing in AI solutions to improve medication adherence, launching new innovative products, investing in environmental friendly estrogen profile, investing in improved progestogen only birth control pills, continue to investing in long-term delivery drugs systems.

The heightened awareness surrounding hormonal contraceptives has empowered individuals to make well-informed decisions aligned with their reproductive goals and lifestyles. This increased awareness enables individuals to make choices that better suit their family planning and lifestyle preferences. In September 2023, the World Health Organization (WHO) reported that global contraception prevalence, including any method, reached 65% in 2022, with modern contraceptive methods at 58.7% among married women in a union. Additionally, the global demand for family planning among women increased from 900 million to nearly 1.1 billion in 2021, with a projected global satisfaction rate of 77.5% among women aged 15-49 in 2022. This elevated awareness significantly propels the hormonal contraceptives market.

The escalating rate of unplanned pregnancies is anticipated to drive the growth of the hormonal contraceptive market. Unplanned pregnancies, categorized as unwanted or unplanned, pose a significant global challenge. Hormonal contraceptives offer a reliable and convenient solution to prevent unplanned pregnancies, giving individuals and couples greater control over family planning. According to the United Nations Population Fund in March 2022, there were 121 million unintended pregnancies globally each year, with Afghanistan projected to experience 4.8 million unintended pregnancies in 2025. Thus, the increasing rate of unplanned pregnancies is expected to fuel the growth of the hormonal contraceptives market.

Companies are innovating by introducing chewable, low-dose oral contraceptives to reduce side effects and enhance daily regimen adherence. The availability of chewable contraceptives as an over-the-counter product aims to improve patient compliance and minimize side effects. Leading companies, such as Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals, are actively participating in this initiative.

Major companies in the hormonal contraceptives market are developing advanced products, such as nonprescription daily oral contraceptives, to improve accessibility and convenience for users. A nonprescription daily oral contraceptive is a type of birth control pill that can be purchased without a prescription from a healthcare provider. For example, in July 2023, Perrigo Company PLC, a US-based manufacturer of private label over-the-counter pharmaceuticals, received approval from the Food and Drug Administration (FDA), a US federal agency responsible for protecting public health, for Opill. Opill is the first nonprescription daily oral contraceptive available to consumers without a prescription. The launch of Opill represents a significant advancement in reproductive health, allowing individuals to access effective birth control without the obstacles of needing a prescription or a healthcare appointment.

Major companies operating in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy care, Mylan Laboratories

North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hormonal contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The hormonal contraceptive market includes revenues earned by entities by blocking the release of eggs from the ovaries and thinning the lining of the uterus to prevent pregnancy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Contraceptives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormonal contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hormonal contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others
2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers
3) By Hormones : Progestin-Only, Combined Hormones
4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels
Subsegments:
1) By Pills: Combined Oral Contraceptives (COCs); Progestin-Only Pills (POPs); Emergency Contraceptive Pills
2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA); Combination Injectable Contraceptives; Subdermal Implants
3) By Vaginal Rings: NuvaRing; Annovera; Other Hormonal Vaginal Rings
4) By Others: Transdermal Patches; Intrauterine Devices (IUDs) with Hormones; Hormonal Implants; Contraceptive Tablets For Men
Companies Mentioned: Bayer AG; Merck & Co. Inc; Viatris; Gedeon Richter; AbbVie
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r25693

1. Executive Summary

2. Hormonal Contraceptives Market Characteristics

3. Hormonal Contraceptives Market Trends And Strategies

4. Hormonal Contraceptives Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Hormonal Contraceptives Growth Analysis And Strategic Analysis Framework

5.1. Global Hormonal Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hormonal Contraceptives Market Growth Rate Analysis
5.4. Global Hormonal Contraceptives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hormonal Contraceptives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hormonal Contraceptives Total Addressable Market (TAM)

6. Hormonal Contraceptives Market Segmentation

6.1. Global Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pills
Injectable Birth Control
Vaginal Rings
Other Products
6.2. Global Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare Settings
Gynaecology Centers
Clinics
Ambulatory Surgical Centers
6.3. Global Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Progestin-Only
Combined Hormones
6.4. Global Hormonal Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Stores
Gynaecology/ Fertility Clinics
E-Commerce
Other Distribution Channels
6.5. Global Hormonal Contraceptives Market, Sub-Segmentation Of Pills, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Combined Oral Contraceptives (COCs)
Progestin-Only Pills (POPs)
Emergency Contraceptive Pills
6.6. Global Hormonal Contraceptives Market, Sub-Segmentation Of Injectable Birth Control, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Depot Medroxyprogesterone Acetate (DMPA)
Combination Injectable Contraceptives
Subdermal Implants
6.7. Global Hormonal Contraceptives Market, Sub-Segmentation Of Vaginal Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
NuvaRing
Annovera
Other Hormonal Vaginal Rings
6.8. Global Hormonal Contraceptives Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transdermal Patches
Intrauterine Devices (IUDs) with Hormones
Hormonal Implants
Contraceptive Tablets For Men

7. Hormonal Contraceptives Market Regional And Country Analysis

7.1. Global Hormonal Contraceptives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hormonal Contraceptives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormonal Contraceptives Market

8.1. Asia-Pacific Hormonal Contraceptives Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormonal Contraceptives Market

9.1. China Hormonal Contraceptives Market Overview
9.2. China Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormonal Contraceptives Market

10.1. India Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormonal Contraceptives Market

11.1. Japan Hormonal Contraceptives Market Overview
11.2. Japan Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormonal Contraceptives Market

12.1. Australia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormonal Contraceptives Market

13.1. Indonesia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormonal Contraceptives Market

14.1. South Korea Hormonal Contraceptives Market Overview
14.2. South Korea Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormonal Contraceptives Market

15.1. Western Europe Hormonal Contraceptives Market Overview
15.2. Western Europe Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormonal Contraceptives Market

16.1. UK Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormonal Contraceptives Market

17.1. Germany Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormonal Contraceptives Market

18.1. France Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormonal Contraceptives Market

19.1. Italy Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormonal Contraceptives Market

20.1. Spain Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormonal Contraceptives Market

21.1. Eastern Europe Hormonal Contraceptives Market Overview
21.2. Eastern Europe Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormonal Contraceptives Market

22.1. Russia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormonal Contraceptives Market

23.1. North America Hormonal Contraceptives Market Overview
23.2. North America Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormonal Contraceptives Market

24.1. USA Hormonal Contraceptives Market Overview
24.2. USA Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormonal Contraceptives Market

25.1. Canada Hormonal Contraceptives Market Overview
25.2. Canada Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormonal Contraceptives Market

26.1. South America Hormonal Contraceptives Market Overview
26.2. South America Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormonal Contraceptives Market

27.1. Brazil Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormonal Contraceptives Market

28.1. Middle East Hormonal Contraceptives Market Overview
28.2. Middle East Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormonal Contraceptives Market

29.1. Africa Hormonal Contraceptives Market Overview
29.2. Africa Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormonal Contraceptives Market Competitive Landscape And Company Profiles

30.1. Hormonal Contraceptives Market Competitive Landscape
30.2. Hormonal Contraceptives Market Company Profiles
- 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Viatris Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Gedeon Richter Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Overview, Products and Services, Strategy and Financial Analysis

31. Hormonal Contraceptives Market Other Major And Innovative Companies

31.1. Pfizer
31.2. Teva Pharmaceuticals
31.3. Mayne Pharma Group Limited
31.4. Lupin Limited
31.5. HLL Lifecare Limited
31.6. Amneal Pharmaceuticals
31.7. DKT International
31.8. Piramal Pharma Limited
31.9. Allergan
31.10. Afaxys Inc.
31.11. Agile Therapeutic
31.12. Cipla Limited
31.13. Glenmark Pharmaceuticals
31.14. Novartis AG
31.15. Sun Pharmaceutical Industries Ltd.

32. Global Hormonal Contraceptives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormonal Contraceptives Market

34. Recent Developments In The Hormonal Contraceptives Market

35. Hormonal Contraceptives Market High Potential Countries, Segments and Strategies

35.1 Hormonal Contraceptives Market In 2029 - Countries Offering Most New Opportunities
35.2 Hormonal Contraceptives Market In 2029 - Segments Offering Most New Opportunities
35.3 Hormonal Contraceptives Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer